Skip to Main Content

Paper Details

Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder.
Science
170
2018
ASD, autism spectrum disorder, binding sites, child, complex disorders, genomes, noncoding functional annotation category, promoter, promoter regions, transcription start site
Author NameAffiliation
Donna M WerlingUCSF Weill Institute for Neurosciences, University of California san francisco
Jeanselle DeaUCSF Weill Institute for Neurosciences, University of California san francisco
Lambertus KleiUniversity of Pittsburgh School of Medicine
Eirene Markenscoff-PapadimitriouUCSF Weill Institute for Neurosciences, University of California san francisco
Sirisha PochareddyDepartment of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine
Nadav AhituvUniversity of California san francisco
Nadav AhituvInstitute for Human Genetics, University of California san francisco
Joseph D BuxbaumSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai
Joseph D BuxbaumMindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai
Joseph D BuxbaumFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Joseph D BuxbaumIcahn School of Medicine at Mount Sinai
Joseph D BuxbaumSeaver Autism Center for Research and Treatment, Icahn School of Medicine at Mount Sinai
Joseph D BuxbaumIcahn School of Medicine at Mount Sinai
Joseph D BuxbaumFriedman Brain Institute, Icahn School of Medicine at Mount Sinai
Joseph D BuxbaumMindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai
Hilary CoonUniversity of Utah School of Medicine
Hilary CoonUniversity of Utah School of Medicine
Mark J DalyProgram in Medical and Population Genetics and the Stanley Center for Psychiatric Research, Broad Institute
Mark J DalyHarvard Medical School
Mark J DalyAnalytical and Translational Genetics Unit and Center for Genomic Medicine, Massachusetts General Hospital
Mark J DalyProgram in Medical and Population Genetics and the Stanley Center for Psychiatric Research, Broad Institute
Mark J DalyAnalytical and Translational Genetics Unit and Center for Genomic Medicine, Massachusetts General Hospital
Mark J DalyHarvard Medical School
Benjamin M NealeProgram in Medical and Population Genetics and the Stanley Center for Psychiatric Research, Broad Institute
Benjamin M NealeHarvard Medical School
Benjamin M NealeAnalytical and Translational Genetics Unit and Center for Genomic Medicine, Massachusetts General Hospital
Benjamin M NealeProgram in Medical and Population Genetics and the Stanley Center for Psychiatric Research, Broad Institute
Benjamin M NealeAnalytical and Translational Genetics Unit and Center for Genomic Medicine, Massachusetts General Hospital
Benjamin M NealeHarvard Medical School
Aaron R QuinlanUniversity of Utah School of Medicine
Aaron R QuinlanUniversity of Utah School of Medicine
Aaron R QuinlanUSTAR Center for Genetic Discovery, University of Utah School of Medicine
John L R RubensteinUCSF Weill Institute for Neurosciences, University of California san francisco
Nenad SestanDepartment of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine
Nenad SestanDepartment of Neuroscience and Kavli Institute for Neuroscience, Yale School of Medicine
Matthew W StateUCSF Weill Institute for Neurosciences, University of California san francisco
Matthew W StateInstitute for Human Genetics, University of California san francisco
Matthew W StateUCSF Weill Institute for Neurosciences, University of California san francisco
Matthew W StateInstitute for Human Genetics, University of California san francisco
Arthur Jeremy WillseyUCSF Weill Institute for Neurosciences, University of California san francisco
Arthur Jeremy WillseyInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California san francisco
Arthur Jeremy WillseyQuantitative Biosciences Institute, University of California san francisco
Arthur Jeremy WillseyUCSF Weill Institute for Neurosciences, University of California san francisco
Arthur Jeremy WillseyInstitute for Neurodegenerative Diseases, UCSF Weill Institute for Neurosciences, University of California san francisco
Arthur Jeremy WillseyQuantitative Biosciences Institute, University of California san francisco
Bernie DevlinUniversity of Pittsburgh School of Medicine
Kathryn RoederCarnegie Mellon University
Kathryn RoederCarnegie Mellon University
Stephan J SandersUCSF Weill Institute for Neurosciences, University of California san francisco
Stephan J SandersInstitute for Human Genetics, University of California san francisco
  • 1 - 50

Datasets